Schubert GE, Pavkovic MB, Bethke-Bedürftig BA (1982) Tubular urachal remnants in adult bladders. J Urol 127:40–42. https://doi.org/10.1016/S0022-5347(17)53595-8

Article  CAS  PubMed  Google Scholar 

Dhillon J, Liang Y, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC (2015) Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol 46:1808–1814. https://doi.org/10.1016/j.humpath.2015.07.021

Article  PubMed  PubMed Central  Google Scholar 

Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, Pisters LL (2003) Multimodality management of urachal carcinoma: the M. D Anderson Cancer Center experience. J Urol 169:1295–1298. https://doi.org/10.1097/01.ju.0000054646.49381.01

Article  PubMed  Google Scholar 

Wang B, Li X, Ming S, Ma X, Li H, Ai Q, Zhang X (2016) Combined extraperitoneal and transperitoneal laparoscopic extended partial cystectomy for the treatment of urachal carcinoma. J Endourol 30:280–285. https://doi.org/10.1089/end.2015.0423

Article  PubMed  Google Scholar 

Mylonas KS, O Malley P, Ziogas IA, El-Kabab L, Nasioudis D (2017) Malignant urachal neoplasms: a population-based study and systematic review of literature. Urol Oncol 35:33.e11-33.e19. https://doi.org/10.1016/j.urolonc.2016.07.021

Article  PubMed  Google Scholar 

Szarvas T, Módos O, Niedworok C, Reis H, Szendröi A, Szász MA, Nyirády P (2016) Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases. Urol Oncol 34:388–398. https://doi.org/10.1016/j.urolonc.2016.04.012

Article  PubMed  Google Scholar 

Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE (1984) Malignant urachal lesions. J Urol 131:1–8. https://doi.org/10.1016/s0022-5347(17)50167-6

Article  CAS  PubMed  Google Scholar 

Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED, Zincke H (2006) Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 107:712–720. https://doi.org/10.1002/cncr.22060

Article  PubMed  Google Scholar 

Bruins HM, Visser O, Ploeg M, Hulsbergen-van de Kaa CA, Kiemeney LALM, Witjes JA (2012) The clinical epidemiology of urachal carcinoma: Results of a large, population based study. J Urol 188:1102–1107. https://doi.org/10.1016/j.juro.2012.06.020

Article  PubMed  Google Scholar 

Chen M, Xue C, Huang R-Q, Ni M-Q, Li L, Li H-F, Yang W, Hu A-Q, Zheng Z-S, An X, Shi Y (2021) Treatment outcome of different chemotherapy in patients with relapsed or metastatic malignant urachal tumor. Front Oncol 11:739134. https://doi.org/10.3389/fonc.2021.739134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galsky MD, Iasonos A, Mironov S, Scattergood J, Donat SM, Bochner BH, Herr HW, Russo P, Boyle MG, Bajorin DF (2007) Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology 69:255–259. https://doi.org/10.1016/j.urology.2006.10.029

Article  PubMed  Google Scholar 

Miyata Y, Sagara Y, Matsuo T, Ohba K, Takahashi H, Sakai H, Kanetake H (2011) Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review. Anticancer Res 31:2335–2338

PubMed  Google Scholar 

Kume H, Tomita K, Takahashi S, Fukutani K (2006) Irinotecan as a new agent for urachal cancer. Urol Int 76:281–282. https://doi.org/10.1159/000091635

Article  PubMed  Google Scholar 

Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, Kasahara Y, Ouchi K, Imai H, Saijo K, Shirota H, Takahashi M, Ishioka C (2023) FOLFIRI chemotherapy for patients with metastatic urachal carcinoma. Anticancer Res 43:5699–5704. https://doi.org/10.21873/anticanres.16775

Article  CAS  PubMed  Google Scholar 

Park I, Lee JL, Yoon S, Shin SJ, Shin SH, Kim JH, Park K, Lee HJ (2025) A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20–03). Cancer Res Treat. https://doi.org/10.4143/crt.2024.1231. Online ahead of print.

Zong L, Chen P (2013) Surgical and chemotherapeutic experience regarding a urachal carcinoma with repeated relapse: case report and literature review. World J Surg Oncol 11:170. https://doi.org/10.1186/1477-7819-11-170

Article  PubMed  PubMed Central  Google Scholar 

Yoshida Y, Yamanaka K, Ueda N, Hirai T, Kishikawa H, Nishimura K, Ichikawa Y (2014) A case of urachal carcinoma with multiple lung metastases treated by TS-1/CDDP chemotherapy. Hinyokika Kiyo 60:147–150. https://doi.org/10.14989/jpnjurol.113.68

Article  PubMed  Google Scholar 

Testa I, Verzoni E, Grassi P, Colecchia M, Panzone F, Procopio G (2014) Response to targeted therapy in urachal adenocarcinoma. Rare Tumors 6:5529. https://doi.org/10.4081/rt.2014.5529

Article  PubMed  PubMed Central  Google Scholar 

Dekeister K, Viguier JL, Martin X, Nguyen AM, Boyle H, Flechon A (2016) Urachal carcinoma with choroidal, lung, lymph node, adrenal, mammary, and bone metastases and peritoneal carcinomatosis showing partial response after chemotherapy treatment with a modified docetaxel, cisplatin and 5-fluorouracil regimen. Case Rep Oncol 9:216–222. https://doi.org/10.1159/000444787

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kapoor R, Darasani N, Bansal A (2016) Rare presentation of urachal adenocarcinoma with skip metastasis to colon. Indian J Urol 32:244–246. https://doi.org/10.4103/0970-1591.185106

Article  PubMed  PubMed Central  Google Scholar 

Ebara S, Kobayashi Y, Sasaki K, Araki M, Sugimoto M, Wada K, Fujio K, Takamoto A, Watanabe T, Yanai H, Nasu Y (2016) A case of metastatic urachal cancer including a neuroendocrine component treated with gemcitabine, cisplatin and paclitaxel combination chemotherapy. Acta Med Okayama 70:223–227. https://doi.org/10.18926/AMO/54423

Article  PubMed  Google Scholar 

Yaegashi H, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A (2019) Metastatic urachal cancer treated effectively with gemcitabine/cisplatin combination chemotherapy and radiotherapy: a case report. Mol Clin Oncol 11:139–142. https://doi.org/10.3892/mco.2019.1865

Article  PubMed  PubMed Central  Google Scholar 

Moreira I, Coelho S, Rodrigues Â, Patrão AS, Maurício MJ (2021) Urachal carcinoma: a case of a rare neoplasm. Curr Probl Cancer 45:100711. https://doi.org/10.1016/j.currproblcancer.2021.100711

Article  PubMed  Google Scholar 

Sharma P, Eigbire G, Sharma R (2021) Small bowel obstruction due to metastatic urachal adenocarcinoma: a rare presentation. Cureus 13:e19705. https://doi.org/10.7759/cureus.19705

Article  PubMed  PubMed Central  Google Scholar 

Zheng H, Song W, Feng X, Zhao H (2021) Metastatic urachal carcinoma treated with several different combined regimens: a case report. Front Oncol 11:662589. https://doi.org/10.3389/fonc.2021.662589

Article  PubMed  PubMed Central  Google Scholar 

Jandou I, Ettanji A, Mohammed E, Moataz A, Mohammed D, Debbagh A, Aboutaieb R (2021) Urachal carcinoma revealed by isolated hematuria. Ann Med Surg (Lond) 63:102193. https://doi.org/10.1016/j.amsu.2021.102193

Article  PubMed  Google Scholar 

Stokkel LE, van Montfoort ML, van Boven HH, Mertens LS, van Rhijn BWG (2021) Two patients with urachal cancer with multifocal adenocarcinoma recurrences in the urothelium of the prostatic and penile urethra. Eur Urol Open Sci 33:56–60. https://doi.org/10.1016/j.euros.2021.08.010

Article  PubMed  PubMed Central  Google Scholar 

Tokita T, Iuchi S, Noto N, Hashizume A, Higuchi K, Miyama K, Kawai M, Nakamura K (2022) A case of urachal carcinoma with high frequency microsatellite insTABILITY (MSI-HIGH) treated by pembrolizumaB. Nihon Hinyokika Gakkai Zasshi 113:68–72. https://doi.org/10.5980/jpnjurol.113.68

Article  PubMed  Google Scholar 

Wang Q, Chen X, Zhang J, Luo Y, Jiang K (2022) Primary urachal signet ring cell carcinoma: a case report. Front Oncol 12:1034245. https://doi.org/10.3389/fonc.2022.1034245

Article  PubMed  PubMed Central  Google Scholar 

Hatano A, Wakaki K, Miyajima N, Komatsu S (2023) Relapsed urachal carcinoma responding to first-line chemotherapy with capecitabine-oxaliplatin plus bevacizumab. IJU Case Rep 6:345–348.